Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityNo recent work listed

Xiang Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6047-0934; OpenAlex author ID A5100368809. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 3 papers · 2021: 2 papers · 2022: 1 paper

Papers 7

  1. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway. Co-author DOI 10.1186/s13046-021-02237-6↗
  2. Dopamine improves chemotherapeutic efficacy for pancreatic cancer by regulating macrophage-derived inflammations. Co-author DOI 10.1007/s00262-020-02816-0↗
  3. Immune subtyping for pancreatic cancer with implication in clinical outcomes and improving immunotherapy. Co-author DOI 10.1186/s12935-021-01824-z↗
  4. Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor microenvironment. Co-author DOI 10.1007/s00262-020-02542-7↗
  5. Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy. Co-author DOI 10.7150/jca.37445↗
  6. CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration. Co-author DOI 10.7150/jca.40517↗
  7. Tumor size classification of the 8th edition of TNM staging system is superior to that of the 7th edition in predicting the survival outcome of pancreatic canc… Co-author DOI 10.1038/s41598-018-28193-4↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Quan Liao · 5 shared papers, 2018–2021 · strength 0.55
  2. Ming Cui · 5 shared papers, 2018–2021 · strength 0.53
  3. Tong Li · 4 shared papers, 2020–2021 · strength 0.46
  4. Jingkai Liu · 4 shared papers, 2020–2021 · strength 0.46
  5. Yupei Zhao · 4 shared papers, 2018–2020 · strength 0.43
  6. Qiaofei Liu · 3 shared papers, 2020–2021 · strength 0.42
  7. Ronghua Zhang · 4 shared papers, 2018–2021 · strength 0.38
  8. Qiaofei Liu · 3 shared papers, 2018–2021 · strength 0.28
  9. Yalu Zhang · 2 shared papers, 2021 · strength 0.26
  10. Huanwen Wu · 2 shared papers, 2020–2021 · strength 0.20
  11. Junyi Gao · 2 shared papers, 2020–2021 · strength 0.20
  12. Menghua Dai · 2 shared papers, 2018–2020 · strength 0.16
  13. Taiping Zhang · 2 shared papers, 2018–2020 · strength 0.16
  14. Junchao Guo · 2 shared papers, 2018–2020 · strength 0.16
  15. Hongcao Lin · 1 shared paper, 2022 · strength 0.15
  16. Chonghui Hu · 1 shared paper, 2022 · strength 0.15
  17. Quanbo Zhou · 1 shared paper, 2022 · strength 0.15
  18. Rufu Chen · 1 shared paper, 2022 · strength 0.15
  19. Zhihua Li · 1 shared paper, 2022 · strength 0.15
  20. Renpeng Xia · 1 shared paper, 2022 · strength 0.15
  21. Shangyou Zheng · 1 shared paper, 2022 · strength 0.15
  22. Quan Liao · 1 shared paper, 2021 · strength 0.15
  23. Sen Yang · 1 shared paper, 2021 · strength 0.12
  24. Mengyi Wang · 1 shared paper, 2020 · strength 0.11
  25. Junya Peng · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.